China Isotope & Radiation Corp
HKEX:1763
China Isotope & Radiation Corp
Operating Income
China Isotope & Radiation Corp
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
C
|
China Isotope & Radiation Corp
HKEX:1763
|
Operating Income
¥941.7m
|
CAGR 3-Years
17%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
Shandong Weigao Group Medical Polymer Co Ltd
HKEX:1066
|
Operating Income
¥2.6B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
7%
|
CAGR 10-Years
N/A
|
|
S
|
Shandong Pharmaceutical Glass Co Ltd
SSE:600529
|
Operating Income
¥814.7m
|
CAGR 3-Years
9%
|
CAGR 5-Years
18%
|
CAGR 10-Years
17%
|
Autobio Diagnostics Co Ltd
SSE:603658
|
Operating Income
¥1.2B
|
CAGR 3-Years
11%
|
CAGR 5-Years
14%
|
CAGR 10-Years
N/A
|
|
Winner Medical Co Ltd
SZSE:300888
|
Operating Income
¥1.8B
|
CAGR 3-Years
45%
|
CAGR 5-Years
26%
|
CAGR 10-Years
N/A
|
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
Operating Income
¥1.8B
|
CAGR 3-Years
20%
|
CAGR 5-Years
19%
|
CAGR 10-Years
N/A
|
See Also
What is China Isotope & Radiation Corp's Operating Income?
Operating Income
941.7m
CNY
Based on the financial report for Dec 31, 2023, China Isotope & Radiation Corp's Operating Income amounts to 941.7m CNY.
What is China Isotope & Radiation Corp's Operating Income growth rate?
Operating Income CAGR 5Y
9%
Over the last year, the Operating Income growth was 7%. The average annual Operating Income growth rates for China Isotope & Radiation Corp have been 17% over the past three years , 9% over the past five years .